期刊文献+

血清促甲状腺激素、甲状腺过氧化物酶抗体和甲状腺球蛋白抗体在甲状腺乳头状癌中的表达及其临床意义 被引量:3

Expressions of serum thyroid stimulating hormone, thyroid peroxidase antibody and thyroglobulin antibody in papillary thyroid carcinoma and their clinical significances
原文传递
导出
摘要 目的探讨血清促甲状腺激素(TSH)、甲状腺过氧化物酶抗体(TPO-Ab)、甲状腺球蛋白抗体(Tg-Ab)水平与甲状腺乳头状癌发生、发展的关系。方法回顾性分析滕州市中心人民医院2021年1月至12月接受手术治疗的574例甲状腺结节患者的临床资料。以组织病理学诊断为金标准,将患者分为甲状腺乳头状癌组(恶性组,267例)及甲状腺良性结节组(良性组,307例),比较两组患者的一般资料及术前血清TSH、TPO-Ab、Tg-Ab水平。采用logistic回归分析术前血清TSH、TPO-Ab、Tg-Ab水平与甲状腺乳头状癌的相关性。结果恶性组与良性组患者年龄、性别比较,差异均无统计学意义(均P>0.05)。恶性组TSH[2.37 mIU/L(1.43 mIU/L,5.09 mIU/L)]、TPO-Ab[17.84 IU/ml(11.94 IU/ml,40.68 IU/ml)]、Tg-Ab[15.69 IU/ml(10.57 IU/ml,132.00 IU/ml)]均高于良性组[TSH 1.60 mIU/L(0.88 mIU/L,2.57 mIU/L),TPO-Ab 14.29 IU/ml(10.00 IU/ml,21.17 IU/ml),Tg-Ab 12.23 IU/ml(10.00 IU/ml,16.51 IU/ml)],差异均有统计学意义(Z值分别为-6.43、-4.60、-6.15,均P<0.05)。多因素logistic回归分析显示,TPO-Ab阳性(OR=0.996,95%CI 0.993~0.999,P=0.013)、Tg-Ab阳性(OR=0.996,95%CI 0.994~0.998,P<0.05)是甲状腺乳头状癌的独立危险因素。结论术前血清TSH、TPO-Ab、Tg-Ab水平与甲状腺乳头状癌关系密切,其中血清TPO-Ab阳性、Tg-Ab阳性是甲状腺乳头状癌的独立危险因素,在甲状腺结节良恶性鉴别诊断中具有重要价值。 Objective To explore the relationship between serum levels of thyroid stimulating hormone(TSH),thyroid peroxidase antibody(TPO-Ab)and thyroglobulin antibody(Tg-Ab)and the development of papillary thyroid carcinoma.Methods The clinical data of 574 patients with thyroid nodules who received surgical treatment in Tengzhou Central People's Hospital from January to December 2021 were retrospectively analyzed.Using histopathological diagnosis as the gold standard,the patients were divided into papillary thyroid carcinoma group(malignant group,267 cases)and benign thyroid nodules group(benign group,307 cases).The clinical data and the preoperative serum TSH,TPO-Ab and Tg-Ab levels were compared between the two groups.The correlation between preoperative serum TSH,TPO-Ab and Tg-Ab levels and papillary thyroid cancer was analyzed by logistic regression.Results There were no statistical differences in the age and gender of patients between the malignant group and the benign group(all P>0.05).TSH[2.37 mIU/L(1.43 mIU/L,5.09 mIU/L)],TPO-Ab[17.84 IU/ml(11.94 IU/ml,40.68 IU/ml)]and Tg-Ab[15.69 IU/ml(10.57 IU/ml,132.00 IU/ml)]in the malignant group were higher than those in the benign group[TSH 1.60 mIU/L(0.88 mIU/L,2.57mIU/L),TPO-Ab 14.29 IU/ml(10.00 IU/ml,21.17 IU/ml),Tg-Ab 12.23 IU/ml(10.00 IU/ml,16.51 IU/ml)],and the differences were statistically significant(Z values were-6.43,-4.60 and-6.15,all P<0.05).Multivariate logistic regression analysis showed that positive TPO-Ab(OR=0.996,95%CI 0.993-0.999,P=0.013)and positive Tg-Ab(OR=0.996,95%CI 0.994-0.998,P<0.05)were independent risk factors for papillary thyroid cancer.Conclusions Preoperative serum TSH,TPO-Ab and Tg-Ab levels are closely related to papillary thyroid cancer,among which positive serum TPO-Ab and positive Tg-Ab are independent risk factors for papillary thyroid cancer and have important values in the differential diagnosis of benign and malignant thyroid nodules.
作者 张艳 龙厚隆 杨汶士 王洪凌 Zhang Yan;Long Houlong;Yang Wenshi;Wang Hongling(Department of Breast and Thyroid Surgery,the Central People's Hospital of Tengzhou,Tengzhou 277500,China)
出处 《肿瘤研究与临床》 CAS 2023年第2期120-123,共4页 Cancer Research and Clinic
关键词 乳头状甲状腺癌 促甲状腺激素 甲状腺过氧化物酶抗体 甲状腺球蛋白抗体 Thyroid cancer,papillary Thyroid stimulating hormone Thyroid peroxidase antibody Thyroglobulin antibody
  • 相关文献

参考文献11

二级参考文献114

  • 1卜军,陈章炜,崔晓通,范凡,高平进,高鑫,高秀芳,葛均波,何奔,胡凯,姜林娣,李小英,李燕,李毅刚,李勇,梁春,刘学波,刘宗军,彭永德,钱菊英,沈成兴,盛长生,孙爱军,王大英,王继光,谢坤,徐磊,闫小响,张瑞岩,赵仙先,周京敏,邹云增.中国成人代谢异常与心血管疾病防治[J].上海医学,2020(3):129-164. 被引量:52
  • 2盖宝东,刘晶,陈桂秋,崔俊生,张德恒,郑泽霖.长春和上海地区居民甲状腺结节性质的对比分析[J].中华普通外科杂志,2005,20(2):95-96. 被引量:19
  • 3吴可光.甲亢性心脏病的诊断与治疗[J].实用内科杂志,1989,9(11):574-575. 被引量:42
  • 4Puxeddu E, Filetti S. The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroidcancer: progress on the road from consensus - to evidence - based practice[lJ. Thyroid, 2009, 19 (11): 1145 -1147.
  • 5Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors[lJ. 1 Cancer Epidemiol, 2013, 2013: 965212.
  • 6Gupta N, Norbu C, Goswarni B, et al. Role of dynamic MRI in differentiating benign from malignant follicular thyroid nodule[J] . Auris Nasus Larynx, 2011, 38 (6): 718 - 723.
  • 7Kung A W, Chau MT, Lao TT, et al, The effect of pregnancy on thyroid nodule formation[J].J Clin Endocrinol Metab, 2002, 87 (3); 1010 -1014.
  • 8Batawil N, Alkordy T. Vltrssonographic features associated with malignancy in cytologically indeterminate thyroid nodules[J]. Eur 1 Surg Oncol, 2014,40 (2); 182 -186.
  • 9Moon WJ, lung SL, LeeJH, et al. Benign and malignant thyroid nodules; US differentiation - multicenter retrospective study[J] . Radiology, 2008, 247 (3); 762 - 770.
  • 10Cappelli C, Castellano M, Pimla I, et al. Thyroid nodule shape suggests malignancy[J]. EmJ Endocrinol, 2006, 155 (1); 27 -31.

共引文献200

同被引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部